The percentage of urine tests that were positive for illicit drugs increased, an ED saw more nonfatal opioid overdoses, and experts offered hospitalist-specific advice on handling substance use disorders.
30 Sep 2020
ACP continues to press the government to do more to address the novel coronavirus disease (COVID-19) and expand coverage of and access to testing and treatment.
18 Mar 2020
The Solidarity trial concluded that remdesivir didn't significantly reduce mortality in ventilated patients and had a small effect on other hospitalized patients. Another study identified factors predicting which patients would benefit from extracorporeal membrane oxygenation (ECMO). The NIH changed its recommendations on convalescent plasma.
11 May 2022
A randomized trial did not find benefit from tocilizumab, and the results were mixed from a smaller trial and retrospective analyses. An editorialist said that evidence does not yet support routine use of the drug for COVID-19 and suggested “wait[ing] out the torrent” of research.
28 Oct 2020
A randomized trial compared two doses of dexamethasone as well as high-flow nasal oxygen, continuous positive airway pressure, and standard oxygen support in ICU patients with COVID-19 and respiratory failure and found no significant differences.
13 Jul 2022
Recent studies compared baricitinib with dexamethasone in COVID-19 patients requiring oxygen, assessed outcomes of extracorporeal membrane oxygenation (ECMO) over time, and found that the vaccines continue to reduce risk for ICU admission and death despite new variants' emergence.
1 Jun 2022
Acute kidney injury (AKI) and diabetic ketoacidosis (DKA) were worse with COVID-19, antibiotics were overused, and an online symptom checker didn't triage safely, but most hospitals had enough ICU beds and preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
17 Mar 2021
Recent studies offered a new method for using lung ultrasound to assess COVID-19 patients, assessed risk of central venous sinus thrombosis (CVST), and looked at a lab test to help predict venous thromboembolism (VTE) and at the effects of restricting visitors.
10 Aug 2022
A Brazilian trial found benefit from tofacitinib in hospitalized patients, while a study of Medicare patients showed racial disparities might stem from differences between hospitals.
23 Jun 2021
This issue focuses mainly on tools to combat COVID-19, including ventilation management, telemedicine, and palliative care. Other articles address Takotsubo cardiomyopathy and vitamin C for sepsis.
13 May 2020